Loading
IP
Innovive Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Herskowitz Neil, was filed 26 Apr 2007.
Innovive Pharmaceuticals, Inc.: what insiders have been doing
Insider filings for Innovive Pharmaceuticals, Inc. are scarce in the SEC (Form 4) feed, the latest one published on 23 September 2008. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
10
Thresholds
n/a
Buy Volume
€36,659
1 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 23 September 2008
Declarations10 total
162,670 shares0Common StockSEC:0001181431-08-054219:0
25,252 shares0Common StockSEC:0001181431-08-054215:0
20,000 shares0Common StockSEC:0001181431-08-053984:0
158,000 shares0Common StockSEC:0001181431-08-053985:0
52,127 shares0Common StockSEC:0001181431-08-053981:0
63,160 shares0Common StockSEC:0001181431-08-053983:0
17,120 shares@ US$3.96Common StockSEC:0001181431-07-047006:0
18,315 shares@ US$2.73Common StockSEC:0001181431-07-027271:0
Canonical exit: 23 Jul 2007 (T+90)
25,252 shares0Common StockSEC:0001181431-07-027259:0
8,560 shares0Common StockSEC:0001181431-07-027259:1
10 of 10 declarations
About Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. is a company focused on developing innovative treatments for serious diseases. It is listed on the XNAS market.
